The potential therapeutic utility of inflammatory modulators in AMD has been illuminated in a recent MR analysis, which established a causal link between increased levels of C-reactive protein and the disease AMD (Han et al., 2020). This evidence concerns the gene CRP and age-related macular degeneration.